Skip to main content

Table 3 Correlations between the Itch NRS, skin pain NRS, and ADSS with other instruments for BREEZE-AD1, BREEZE-AD2, and BREEZE-AD5 at baseline and week 16

From: Psychometric properties of the itch numeric rating scale, skin pain numeric rating scale, and atopic dermatitis sleep scale in adult patients with moderate-to-severe atopic dermatitis

Measure

Correlation

BREEZE-AD1a correlation

BREEZE-AD2a correlation

BREEZE-AD5a correlation

Baseline

Week 16

Baseline

Week 16

Baseline

Week 16

Itch NRS

ClinRO

EASI

0.229

0.398

0.223

0.505

0.225

0.498

PRO

PGI-S-AD

0.762

0.767

0.759

0.788

0.752

0.834

DLQI

0.495

0.590

0.506

0.586

0.544

0.666

POEM

0.483

0.607

0.586

0.640

0.505

0.667

Skin pain NRS

ClinRO

EASI

0.222

0.338

0.225

0.455

0.251

0.444

PRO

PGI-S-AD

0.707

0.691

0.727

0.710

0.689

0.768

DLQI

0.529

0.549

0.591

0.582

0.586

0.658

POEM

0.474

0.575

0.634

0.621

0.536

0.657

ADSS item 1

ClinRO

EASI

0.281

0.363

0.140

0.403

0.233

0.376

PRO

PGI-S-AD

0.651

0.582

0.624

0.597

0.627

0.670

DLQI

0.570

0.576

0.598

0.554

0.522

0.608

POEM

0.507

0.508

0.531

0.518

0.499

0.582

ADSS item 2

ClinRO

EASI

0.245

0.254

0.131

0.357

0.223

0.350

PRO

PGI-S-AD

0.451

0.424

0.435

0.446

0.449

0.495

DLQI

0.445

0.486

0.447

0.486

0.411

0.516

POEM

0.368

0.436

0.468

0.489

0.422

0.473

ADSS item 3

ClinRO

EASI

0.298

0.237

0.152

0.394

0.187

0.300

PRO

PGI-S-AD

0.555

0.636

0.603

0.641

0.639

0.809

DLQI

0.516

0.466

0.526

0.505

0.516

0.581

POEM

0.439

0.472

0.460

0.474

0.403

0.563

  1. ADSS, Atopic Dermatitis Sleep Scale; ClinRO, clinician-reported outcome; DLQI, Dermatology Quality of Life Index; EASI, Eczema Area and Severity Index; NRS, Numeric Rating Scale; PGI-S-AD, Patient Global Impression of Severity–Atopic Dermatitis; POEM, Patient Oriented Eczema Measure; PRO, patient-reported outcome
  2. aSpearman’s correlation coefficients were calculated as correlations between assessments and continuous reference measures. Concurrent validity was small if the resulting coefficient was < 0.4, moderate if the coefficient was > 0.4–0.7, and large if the coefficient was > 0.7